Keep in mind that there were only a total of three 3-point MACE events in the post-hoc analysis of the SUSTAIN/ASSURE diabetes patients (2 deaths in placebo group, 1 non-fatal MI in apabetalone group, no strokes reported in either). Those SUSTAIN/ASSURE post--hoc %RRRs are mostly driven by the "soft" events that are not part of the BETonMACE primary outcome tally. See here.
BearDownAZ